A photo of Timothy Dribin.

Assistant Professor, UC Department of Pediatrics

513-636-7966

Board Certified

My Biography & Research

Biography

My clinical specialty is pediatric emergency medicine. I was influenced to become a physician by my experiences with my pediatrician while growing up. I also had wonderful mentors in medical school and during my residency and fellowship.

My area of research interest is anaphylaxis, which is a severe, potentially life-threatening acute allergic reaction. I care for a lot of children with anaphylaxis in the emergency department (ED), and I’m driven to learn how to improve the recognition and management of anaphylaxis both in the ED and community. My work aims to determine how long children should be observed in the ED or inpatient setting to monitor for biphasic reactions. Additionally, my research team seeks to identify diagnostic and predictive anaphylaxis biomarkers and to evaluate barriers to the delivery of anaphylaxis best practices in the ED and outpatient setting. I am grateful for the patients and families who participate in my research in the hope that we can improve the care and outcomes of children with and at risk of anaphylaxis.

I am a board certified pediatrician (2015) and pediatric emergency medicine physician (2019). I’m honored to have received the Center for Clinical and Translational Science and Training (CCTST) KL2 award (2021) and the research prize through the Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) through the section of emergency medicine of the American Academy of Pediatrics (2019).

Clinical Interests

Emergency medicine

Research Interests

Anaphylaxis; allergic reactions; situational awareness

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Clinical Divisions

Emergency Medicine

Research Divisions

Emergency Medicine

My Education

BS: Biology, University of Missouri-Columbia, Columbia, MO, 2008.

MD: University of Missouri-Columbia, Columbia, MO, 2012.

Residency: Pediatrics, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA, 2015.

Fellowship: Pediatric Emergency Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, 2018.

My Publications

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach. Greenhawt, M; Abrams, EM; Shaker, M; Chu, DK; Kahn, D; Akin, C; Alqurashi, W; Arkwright, P; Baldwin, JL; Ben-Shoshan, M; et al. Journal of Allergy and Clinical Immunology: In Practice. 2021.

PEMCRC anaphylaxis study protocol: a multicentre cohort study to derive and validate clinical decision models for the emergency department management of children with anaphylaxis. Dribin, TE; Michelson, KA; Vyles, D; Neuman, MI; Brousseau, DC; Mistry, RD; Dayan, PS; Zhang, N; Viswanathan, S; Witry, J; et al. BMJ Open. 2021; 11.

Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study. Dribin, TE; Sampson, HA; Camargo, CA; Brousseau, DC; Spergel, JM; Neuman, MI; Shaker, M; Campbell, RL; Michelson, KA; Rudders, SA; et al. Journal of Allergy and Clinical Immunology. 2020; 146:1089-1096.

Is a Lower Initial Epinephrine Dose Associated With Receipt of Additional Epinephrine Among Children Hospitalized With Anaphylaxis? A Retrospective Cohort Study. Dribin, TE; Michelson, KA; Zhang, Y; Schnadower, D; Neuman, MI. Clinical Pediatrics. 2020; 59:921-924.

Are Children with a History of Asthma More Likely to Have Severe Anaphylactic Reactions? A Retrospective Cohort Study. Dribin, TE; Michelson, KA; Zhang, Y; Schnadower, D; Neuman, MI. Journal of Pediatrics. 2020; 220:159-164.e2.

Timing and predictors of repeat epinephrine administration among children hospitalized for anaphylaxis. Dribin, TE; Michelson, KA; Monuteaux, MC; Schnadower, D; Neuman, MI. Journal of Allergy and Clinical Immunology: In Practice. 2020; 8:1400-1402.e2.

Trends in emergency care for anaphylaxis. Michelson, KA; Dribin, TE; Vyles, D; Neuman, MI. Journal of Allergy and Clinical Immunology: In Practice. 2020; 8:767-768.e2.

Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application. Walters, E; Wurster Ovalle, V; Yin, S; Dribin, T. BMJ Case Reports. 2020; 13.

Identification of children with anaphylaxis at low risk of receiving acute inpatient therapies. Dribin, TE; Michelson, KA; Monuteaux, MC; Stack, AM; Farbman, KS; Schneider, LC; Neuman, MI. PLoS ONE. 2019; 14.

Reducing Hospitalization Rates for Children With Anaphylaxis. Farbman, KS; Michelson, KA; Neuman, MI; Dribin, TE; Schneider, LC; Stack, AM. Pediatrics. 2017; 139.